Who owns Relmada Therapeutics Inc?
- Ticker: RLMD
- CUSIP Number: 75955j402
Tip: Access positions for across all investors
Analyze quarterly positions in Relmada Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Relmada Therapeutics stock
Who bought or sold Relmada Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Marshall Wace | 3.2M | $15M | 1072% | Dec 2025 |
|
| Ikarian Capital | 3.1M | $15M | 66% | Dec 2025 |
|
| Braidwell | 1.6M | $7.6M | 100% | Dec 2025 |
|
| BlackRock | 1.3M | $6.1M | 150% | Dec 2025 |
|
| Vanguard Group | 1.2M | $5.8M | 187% | Dec 2025 |
|
| Opaleye Management | 935k | $4.5M | 100% | Dec 2025 |
|
| Geode Capital Management | 855k | $4.1M | 189% | Dec 2025 |
|
| Boothbay Fund Management | 835k | $4.0M | 20% | Dec 2025 |
|
| Driehaus Capital Management | 740k | $1.5M | 0% | Sep 2025 |
|
| CI Private Wealth | 720k | $3.4M | 248% | Dec 2025 |
|
| Acadian Asset Management | 527k | $2.5M | -10% | Dec 2025 |
|
| Susquehanna International | 433k | $2.1M | 112% | Dec 2025 |
|
| Diadema Partners | 389k | $1.9M | 100% | Dec 2025 |
|
| State Street Corporation | 321k | $1.5M | 215% | Dec 2025 |
|
| AdvisorShares Investments | 320k | $1.5M | -21% | Dec 2025 |
|
| Jane Street | 283k | $1.4M | 231% | Dec 2025 |
|
| Parsons Capital Management | 263k | $1.3M | 61% | Dec 2025 |
|
| Persistent Asset Partners | 231k | $1.1M | 100% | Dec 2025 |
|
| Deutsche Bank Aktiengesellschaft | 225k | $1.1M | 0% | Dec 2025 |
|
| Point72 Asset Management | 187k | $905k | 100% | Dec 2025 |
|
| Renaissance Technologies | 185k | $894k | 9% | Dec 2025 |
|
| Two Sigma Investments | 174k | $349k | 82% | Sep 2025 |
|
| Goldman Sachs Group | 169k | $818k | 100% | Dec 2025 |
|
| Northern Trust | 166k | $799k | 180% | Dec 2025 |
|
| Rbf Capital | 163k | $328k | 0% | Sep 2025 |
|
| Eudaimonia Asset Management | 163k | $785k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 156k | $751k | 100% | Dec 2025 |
|
| Seven Fleet Capital Management | 154k | $744k | 100% | Dec 2025 |
|
| Squarepoint Ops | 138k | $668k | 100% | Dec 2025 |
|
| We Are One Seven | 100k | $483k | 0% | Dec 2025 |
|
| Sei Investments | 99k | $478k | 100% | Dec 2025 |
|
| Caption Management | 74k | $356k | 100% | Dec 2025 |
|
| ExodusPoint Capital Management | 69k | $333k | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 66k | $318k | 100% | Dec 2025 |
|
| Barclays | 60k | $290k | 500% | Dec 2025 |
|
| LMR Partners | 56k | $269k | 0% | Dec 2025 |
|
| Quadrature Capital | 53k | $258k | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 53k | $256k | 100% | Dec 2025 |
|
| apricus wealth | 48k | $229k | 0% | Dec 2025 |
|
| Pale Fire Capital SE | 45k | $215k | 100% | Dec 2025 |
|
| UBS Group | 42k | $200k | -31% | Dec 2025 |
|
| XTX Topco | 41k | $199k | 100% | Dec 2025 |
|
| Two Sigma Advisers | 39k | $78k | 55% | Sep 2025 |
|
| AlTi Global | 32k | $154k | 0% | Dec 2025 |
|
| ADAR1 Capital Management | 31k | $149k | 100% | Dec 2025 |
|
| Mangrove Partners | 27k | $132k | 100% | Dec 2025 |
|
| Hudson Bay Capital Management | 26k | $127k | 100% | Dec 2025 |
|
| Graham Capital Management | 26k | $124k | 100% | Dec 2025 |
|
| Robertson Stephens Wealth Management | 25k | $121k | 0% | Dec 2025 |
|
| Leucadia National Corporation | 22k | $105k | 100% | Dec 2025 |
|
| Pandora Wealth | 20k | $97k | 0% | Dec 2025 |
|
| Simplex Trading | 19k | $90k | -65% | Dec 2025 |
|
| Citadel Advisors | 18k | $37k | 100% | Sep 2025 |
|
| Virtu Financial | 18k | $85k | 100% | Dec 2025 |
|
| Lighthouse Investment Partners | 16k | $77k | 100% | Dec 2025 |
|
| Tortoise Investment Management | 14k | $67k | 0% | Dec 2025 |
|
| Lido Advisors | 14k | $28k | 0% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 13k | $64k | 100% | Dec 2025 |
|
| Pensionmark Financial Group | 10k | $50k | -2% | Dec 2025 |
|
| Bedel Financial Consulting | 10k | $48k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 3.0k | $15k | 3169% | Dec 2025 |
|
| Hanson McClain Advisors | 2.0k | $9.7k | 100% | Dec 2025 |
|
| American Capital Advisory | 2.0k | $9.4k | 0% | Dec 2025 |
|
| Farther Finance Advisors | 684.00 | $3.3k | -18% | Dec 2025 |
|
| SBI Securities | 57.00 | $275.002200 | -44% | Dec 2025 |
|
| Advisor Group Holdings | 5.00 | $24.000000 | 0% | Dec 2025 |
|
| Front Row Advisors | 2.00 | $10.000000 | 0% | Dec 2025 |
|
| Royal Bank of Canada | 1.00 | $0 | 0% | Sep 2025 |
|
Who sold out of Relmada Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tower Research Capital | Sep 2025 | 1.6k | $3.2k |